Related by context. All words. (Click for frequent words.) 74 therapies 72 cancer therapeutics 71 novel therapeutics 71 monoclonal antibodies 70 biotherapeutics 70 immunotherapeutics 69 protein therapeutics 69 therapeutic antibodies 69 stem cell therapeutics 69 small molecule 68 biopharmaceuticals 68 therapeutic monoclonal antibodies 67 small molecule therapeutics 67 antibody therapeutics 66 therapeutic 66 oncology therapeutics 66 RNAi 65 siRNA therapeutics 65 therapeutic proteins 65 therapeutic antibody 65 antiviral therapeutics 65 novel peptide 65 RNAi therapeutics 65 biopharmaceutical 65 molecular diagnostics 64 oncology 64 CNS disorders 64 regenerative medicine 64 anticancer therapies 64 biologics 64 anti infective 63 monoclonal antibody therapeutics 63 biomarkers 63 biologic therapeutics 63 disease modifying 63 molecular biomarkers 63 peptide therapeutics 63 diagnostic assays 63 inflammatory diseases 62 MAbs 62 biomarker discovery 62 biologic therapies 62 investigational therapies 62 monoclonal antibody 62 immunotherapies 62 biotherapeutic 62 anticancer agents 62 antibody therapies 62 preclinical 62 immunotherapy 62 neurodegenerative diseases 62 biomarker 62 theranostics 61 cancer immunotherapies 61 immunologic diseases 61 anti infective treatments 61 molecular diagnostic 61 DOS# 61 RNAi therapeutic 61 Nanobody 61 anticancer therapeutics 61 rxRNA 61 immunological diseases 61 kinase inhibitors 61 immunotherapeutic 61 unmet medical 60 therapeutic monoclonal antibody 60 ocular diseases 60 novel peptides 60 nanomedicines 60 microRNA therapeutics 60 proteasome inhibitors 60 KineMed 60 anti infectives 60 biologic 60 histone deacetylase HDAC inhibitors 60 antisense drugs 60 diagnostic biomarkers 60 ophthalmic diseases 60 siRNA delivery 60 therapeutic peptides 60 chemical entities NCEs 59 prostone 59 humanized monoclonal antibodies 59 Stapled Peptide 59 RNAi therapeutic targeting 59 nanomedicine 59 novel immunotherapies 59 XmAb ® 59 efficacious treatments 59 therapeutic peptide 59 immunomodulators 59 Tranzyme 59 small molecule inhibitors 59 isoform selective 59 Nanobody ® 59 stem cell therapies 59 PROT biotechnology 59 Ambrx 59 pharmacogenetics 59 regenerative therapies 59 Factor VIIa 59 protein kinase inhibitors 59 MEK inhibitors 59 rxRNA compounds 59 RNA therapeutics 59 mAbs 59 Anaphore 59 IAP inhibitors 59 ALN PCS 59 systemic RNAi 59 novel antibody therapeutics 59 epigenetic enzymes 59 predictive toxicology 59 SARMs 59 Fibrocell Science 58 novel anti infective 58 cancer immunotherapy 58 monoclonal antibody therapies 58 autoimmune inflammatory 58 LNP formulations 58 ophthalmic therapeutics 58 anticancer drugs 58 MDRNA proprietary 58 siRNA 58 epigenetic therapeutics 58 oncology indications 58 dermatology therapies 58 Anticalins R 58 recombinant protein therapeutics 58 protein biomarkers 58 targeted radiotherapeutic 58 NTDDS 58 molecular diagnostic tests 58 renin inhibitors 58 autoimmune diseases 58 histone methyltransferases HMTs 58 novel RNAi therapeutics 58 oncolytic viruses 58 biologicals 58 Phage Pharmaceuticals 58 antisense oligonucleotides 58 immune modulators 58 Enkephalin 58 ophthalmology dermatology cardiovascular disease 58 oncolytic 58 therapeutic modality 58 PROfusion 58 NASDAQ CYTR biopharmaceutical 58 LNPs 58 regenerative medicine therapies 58 NovaBay Aganocide compounds 58 Squalamine 58 pharmacological chaperone 58 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 58 cellular immunotherapy 58 sirtuin therapeutics 57 molecular imaging radiopharmaceuticals 57 RNA interference RNAi therapeutics 57 adrenal steroid hormones 57 proteomics 57 antiviral compounds 57 biomarker assays 57 molecular imaging 57 small molecule agonists 57 HepDirect R 57 HSP# inhibitors 57 predictive biomarkers 57 Vaccinex 57 molecularly targeted therapies 57 diseases fat malabsorption 57 therapeutics diagnostics 57 theranostic 57 Monoclonal antibodies 57 Curaxin 57 mAb 57 neuro inflammatory 57 immuno inflammatory diseases 57 photodisinfection 57 oligonucleotide therapeutics 57 G Protein Coupled 57 antiviral therapies 57 chemotherapeutics 57 Adnectin 57 RNA antagonists 57 siRNA compounds 57 Pervasis 57 proliferative diseases 57 Nanobodies ® 57 rxRNA TM compounds 57 Intellikine 57 liposomal delivery 57 cytotoxics 57 siRNA therapeutic 57 Nasdaq PARD biopharmaceutical 57 gene therapy 57 Celator 57 kidney urologic 57 multitargeted 57 aptamers 57 Nanobodies 57 Charlesson 57 preclinical compounds 57 biosurgical 57 VitiGam 57 tiapamil 57 ddRNAi 57 Panzem 57 treatments 57 topical dermatology 57 biased ligand 57 Archexin 57 neuro degenerative diseases 57 monoclonal 57 polymerase inhibitors 57 TRV# [001] 56 therapeutic modalities 56 DiLA2 56 small molecule modulators 56 human antibody therapeutics 56 ESBA# 56 Stapled Peptides 56 Soliris eculizumab 56 aptamer therapeutics 56 RONDEL ™ 56 novel immunotherapeutic 56 anticancer compounds 56 personalized medicine 56 biomarker identification 56 SGLT Inhibitors 56 antibody 56 companion diagnostics 56 IAP inhibitor 56 NASDAQ OPXA 56 thetreatment 56 novel antiviral therapeutics 56 TLR Therapeutics 56 pharmacogenomics 56 therapeutic regimens 56 immune modulatory 56 immuno modulatory 56 antisense drug 56 Theranostics 56 targeting PCSK9 56 diagnostic molecular imaging 56 epothilones 56 selective androgen receptor modulators 56 molecular assays 56 recombinant therapies 56 Symadex 56 LentiVector technology 56 polyclonal antibodies 56 Receptos 56 MTP inhibitor 56 GPCR targets 56 Metallophile ™ Technology 56 Vegenics 56 Aviptadil 56 proteasome inhibitor 56 monoclonal antibodies MAbs 56 cardiometabolic disorders 56 CCR9 antagonist 56 inflammatory autoimmune 56 PI3K inhibitors 56 HSP# inhibitor 56 immune modulation 56 Achaogen 56 commercializing therapeutic 56 TLR8 56 humanized antibodies 56 Supernus Pharmaceuticals 56 vascular disrupting agents 56 XmAb 56 beta secretase inhibitors 56 Chemokine 56 novel immunomodulatory 56 prostones 56 prophylactic vaccines 56 molecular chaperone 56 GI motility disorders 56 epothilone 56 NuMimetic TM 56 commercialize microRNA 56 Liprotamase 56 Regenerative medicine 56 vaccines oncolytic virus 56 liposome formulations 56 investigational compounds 56 RNAi molecules 56 bluebird bio 56 vitamin D analogs 56 bio therapeutics 56 Homspera TM 56 humanized antibody 56 Symphogen 56 specialty pharmaceutical 56 Tß4 56 medicinal chemistry 56 radionuclide therapy 56 TLR9 agonists 56 proteins peptides 55 Cylene 55 RECOTHROM R 55 identify protein biomarkers 55 OvaRex R 55 topical anti infective 55 A3 adenosine receptor 55 anticoagulant reversing agent 55 immunoregulation 55 Phylomer ® 55 prodrugs 55 adenoviral 55 anti CD3 55 fibrotic diseases 55 genomics 55 Litx 55 p# inhibitor 55 LentiVector 55 FivePrime 55 immunotherapy treatments 55 Onconase 55 glycobiology 55 aTyr Pharma 55 immunology 55 delta isoform 55 CD# antibody [001] 55 ophthalmic pharmaceutical 55 Fc fusion protein 55 Anticalins ® 55 diagnostic prognostic 55 targeted radiotherapeutics 55 immunotoxin 55 peptide mimetics 55 intracellular signaling pathways 55 TÎ ² 4 55 psoriasis rheumatoid arthritis 55 Receptors GPCRs 55 fusion proteins 55 metabolic diseases 55 Aegis Therapeutics 55 anti angiogenic drugs 55 neurological diseases 55 Chrysalin 55 miRNA therapeutics 55 immune modulating 55 biobetter 55 novel therapeutic antibodies 55 Locked Nucleic Acid LNA 55 NexACT 55 viral diseases 55 compound COTI 55 selective inhibition 55 commercializing anti infective 55 ATL# [001] 55 Immunotherapeutic 55 neuroprotection 55 siRNA sequences 55 specialty pharmaceuticals 55 romazarit 55 transdermal drug 55 CB1 antagonists 55 resolvins 55 humanized anti 55 lentiviral vectors 55 neurodegenerative disorders 55 clinically validated targets 55 immunotherapeutic approaches 55 bioactive lipids 55 FGFR 55 Nautilus Biotech 55 lipid nanoparticles 55 ArQule Kinase Inhibitor Platform 55 FOLOTYN ® 55 diagnostics 55 cyclophilin inhibitors 55 oncology endocrinology 55 Guanilib 55 DNAi 55 belinostat 55 proprietary LNA 55 SGLT inhibitors 55 tranilast 55 SNALP 55 neuronal nicotinic receptors NNRs 55 recombinant vaccines 55 AEG# 55 Antisense 55 HCV protease inhibitors 55 PARP inhibitors 55 AMPK activators 55 aesthetic dermatology 55 Aegera 55 functional genomics 55 dermatological diseases 55 adrenergic regulation 55 oral antiviral 55 ALN TTR 55 recombinant antibodies 55 resolvin 55 ophthalmology oncology 55 oxazolidinone 55 chronic inflammatory 55 metabolic disorders 55 Immunotherapy 55 molecularly targeted 55 anticancer therapy 55 Therapeutic antibodies 55 nanopharmaceuticals 55 Agios Pharmaceuticals 55 histone deacetylase HDAC 55 treating neuropathic pain 55 OncoVEX 55 Fleximer R 55 deacetylase inhibitors 55 GPCR 55 antisense 55 immunology oncology 55 Akebia Therapeutics 55 chemotherapeutic 55 Personalized Immunotherapy 55 BCR ABL inhibitors 55 renin inhibition 55 biotechnology 55 targeting CD# 54 SGLT2 inhibitors 54 SMIP 54 Cellzome 54 molecular imaging radiopharmaceutical 54 Intarcia 54 monoclonal antibody mAb 54 humanized monoclonal 54 Hsp# inhibition 54 PDE4 inhibitor 54 bionanotechnology 54 Plexxikon 54 interventional therapies 54 Exelixis compounds 54 nanobiotechnology 54 specialty pharma 54 therapeutic radiopharmaceuticals 54 NEUGENE R 54 Azedra 54 proprietary Dicer Substrate Technology 54 Anticalins 54 Pazopanib 54 fatty acid biosynthesis 54 biotherapies 54 CTLA4 Ig 54 CAMBRIDGE Mass. Alnylam Pharmaceuticals 54 JAK1 54 anti infective compounds 54 Monoclonal antibody 54 Interferon beta 54 humanized monoclonal antibody 54 Nasdaq ENZN 54 antisense therapeutics 54 Friedreich Ataxia FRDA 54 translational medicine 54 neurology immunology 54 investigational humanized monoclonal antibody 54 Brussels THR 54 Lycera 54 CB2 selective 54 Dyax phage display 54 Provectus Pharmaceuticals specializes 54 diagnostic biomarker 54 neuropathic pain 54 genetic biomarkers 54 nicotinic acetylcholine receptor 54 FoldRx 54 MAXY VII 54 HGS# 54 diabetic nephropathy 54 DiaKine 54 mTOR inhibitors 54 OHR/AVR# 54 ANTISENILIN ® 54 peptides 54 Amarantus 54 treat gastrointestinal disorders 54 antibody fragment therapeutics 54 histone deacetylase inhibitors 54 M2 subunit 54 Adnectins 54 molecular radiotherapeutics 54 recombinant human 54 Inc. Nasdaq NLTX 54 Etubics 54 anticancer agent 54 OTCBB NVLT biopharmaceutical 54 antitumoral 54 epigenetic therapies 54 Abiraterone acetate 54 Omacetaxine 54 immunomodulatory 54 ZFN technology 54 Novosom 54 mucosal vaccines 54 ADME Tox 54 antisense inhibitors 54 topical formulations 54 EGFR HER 54 catalytic antioxidant compounds 54 Affibody ® molecules 54 iPSC technology 54 drug GAP #B# 54 intranasal delivery 54 nitric oxide donating 54 purinergic receptors P#X# 54 ErbB3 HER3 54 Ostabolin C TM 54 degenerative disorders 54 Avila Therapeutics 54 Semafore 54 OTCBB NRGX biotechnology 54 prognostic markers 54 topically delivered 54 Nasdaq IDIX biopharmaceutical 54 novel peptide therapeutics 54 Fibroblast Growth Factor Receptor 54 liposomal 54 AMPAKINE 54 diagnostics therapeutics 54 autologous cell 54 adenosine A2A 54 Myocet 54 GPCRs 54 protein misfolding diseases 54 CYT# novel 54 bioinnovation 54 Scancell 54 Stem Cell Innovations 54 ibudilast 54 PI3K/mTOR 54 shRNA libraries 54 cardiovascular metabolic 54 PORxin 54 AMPAKINE compounds 54 antimitotic 54 Vipin K. 54 Cobalamin 54 histone deacetylase inhibitor 54 Stemgent 54 Oncaspar 54 VEGF inhibitors 54 Nuron Biotech 54 monoclonal antibodies mAbs 54 Dicer Substrate Technology 54 ELND-#/AZD-# 54 Prodarsan R 54 PEGylation 54 OXIGON TM 54 Drug Discovery 54 recombinant protein 54 peptidomimetic 54 myeloproliferative disorders 54 cardio renal 54 Combivir Kivexa 54 Adenosine Therapeutics 54 lipid nanoparticle 54 small molecule tyrosine 54 immunotherapeutic vaccine 54 SCYNEXIS 54 Fc fusion proteins 54 potently inhibit 54 BHT DNA 54 humanised monoclonal antibody 54 OTCBB OHRP 54 RNA antagonist 54 autoimmune disorders 54 TREANDA 54 personalized immunotherapy 54 Ceflatonin 54 TNF alpha inhibitors 54 NYSE Amex RNN 54 PDGF receptor 54 SERMs 54 HepDirect 54 recombinant polyclonal antibodies 54 vaccine adjuvant 54 Oramed 54 gastrointestinal GI disorders 54 nicotinic alpha 7 54 Panzem R 54 photodynamic 54 pharmacogenomic tests 54 P#X# antagonist 54 EHT AGN 54 NeuroSolutions 54 Logical Therapeutics 54 Cethrin R 54 Rebif ® 54 JAK2 inhibitors 54 BioSilicon TM 54 Neuradiab 54 mitotic kinesins 54 Ception Therapeutics 54 anti CD# antibodies 54 adipose derived stem cell 54 commercializing novel 54 antagomirs 54 EndoTAG 54 Spiegelmers ® 54 HIV integrase inhibitors 54 OPKO 54 kinase profiling 54 oncology immunology 54 lipidomics 54 antiangiogenesis therapies 54 Fleximer 54 cognitive impairment associated 54 dAbs 54 metabolite identification 54 Applied NeuroSolutions 54 Sphingomab TM 54 BioSeek 54 INS# [001] 54 ophthalmic indications 54 Corixa Corporation 54 Fabry Disease 54 IMiDs R 54 Nasdaq HALO biopharmaceutical 54 microtubule inhibitor 54 Curaxins 54 polyclonal antibody 54 MEK inhibitor 53 VEGF Trap 53 insulin analogs 53 Inc. OTCBB LPTN 53 diagnostic tests 53 engineered RAP peptides 53 commercialize deforolimus 53 New Chemical Entities 53 Mesd 53 GammaCan 53 JAK3 53 DPX Survivac 53 peptide 53 PI3K delta 53 regenerative therapeutics 53 iPSC 53 microRNA 53 ProtAffin 53 Phylomer 53 Molecular diagnostics 53 otelixizumab 53 triphendiol 53 Synageva 53 gene expression profiling 53 Helix BioMedix 53 Personalized medicine 53 NIC5 53 Myolimus 53 vidofludimus 53 clinical trials 53 melanocortin receptor agonists 53 PI3 kinase inhibitors 53 oxidative stress inducer 53 biologic treatments 53 ghrelin antagonist 53 histone deacetylase HDAC inhibitor 53 neurodegenerative disease 53 optimized siRNA 53 Pervasis Therapeutics Inc. 53 Levulan PDT 53 TLR9 agonist 53 Tolerx 53 Onalta 53 Dr. Aiping Young 53 stem cell therapy 53 direct thrombin inhibitors 53 nanocarriers 53 rheumatoid arthritis multiple sclerosis 53 preclinical studies 53 ZFP TF 53 CB2 receptor 53 subcutaneous immunoglobulin 53 Tovaxin ® 53 Asthma COPD 53 PsychoGenics 53 IIB ActRIIB 53 Phenomix Corporation 53 immuno oncology 53 kinase inhibition 53 DXL# 53 peptide antigens 53 Zenyaku Kogyo 53 RNAi therapeutic targeting PCSK9 53 JAK inhibitors 53 Homspera 53 fibrotic disorders 53 Urokinase 53 Spiegelmer 53 AutoloGel tm System 53 Calistoga Pharmaceuticals 53 erlotinib Tarceva 53 prophylactic vaccine 53 myelofibrosis polycythemia vera 53 Zemiva TM 53 RhuDex ® 53 mimetics 53 iCeutica 53 ADME 53 short interfering RNA 53 BiTE 53 sd rxRNA compounds 53 biomaterials 53 Sangamo ZFP technology 53 synthetic peptides 53 Campath ® 53 AAV vector 53 ocular inflammatory 53 tkRNAi 53 Hybridon 53 transfection reagents 53 P#X# 53 preclinical toxicology 53 orally bioavailable 53 Tarvacin TM 53 ATG Fresenius S 53 thrombotic diseases 53 echinocandins 53 Tarmogen 53 DsiRNA 53 Cellerant 53 clinically validated 53 Profectus BioSciences 53 anti angiogenic agents 53 Janus Kinase 53 plasma proteins 53 Multiferon R 53 Garo H. 53 molecular abnormalities 53 GeneICE 53 antisense inhibitor 53 rheumatoid arthritis psoriasis Crohn 53 AKT inhibitor 53 Tranzyme Pharma 53 pharmacogenetic test 53 VEGF receptor 53 Lixivaptan 53 Zingo TM 53 Aeolus Pharmaceuticals 53 Epizyme 53 CXCR4 receptor 53 druggable targets 53 GAP #B# 53 Onco TCS 53 MAXY G# 53 DNA methylation biomarkers 53 insulin sensitizer 53 NCEs 53 CobaCyte 53 Novartis Gleevec 53 signal transduction inhibitors 53 beta interferons 53 engineered proteases 53 Sutent sunitinib 53 Revance 53 ProLindac TM 53 chemotherapeutic agents 53 ALN TTR# 53 ERYtech Pharma 53 Adherex Technologies 53 Protein Kinase C 53 tumor antigens 53 Flutiform TM 53 Aquinox 53 antithrombotic agents 53 NASDAQ BTRX pharmaceutical 53 Zybrestat 53 targeted antifolate 53 NNR Therapeutics 53 Monoclonal Antibodies 53 eTag assays 53 Amphotericin B 53 insulin analogues 53 Spiegelmers R 53 lysosomal storage disorders 53 RNAi compounds 53 CNS hematology oncology 53 ANG# 53 Bioral 53 aTyr 53 JAK2 inhibitor 53 pancreatic enzyme replacement 53 drug conjugates ADCs 53 commercializes therapeutics 53 selective kinase inhibitors 53 nonviral 53 crofelemer 53 autoimmune uveitis 53 Hsp# inhibitor 53 Anticalin R 53 synergistic combinations 53 NeurAxon Inc. 53 Mesoblast Limited ASX MSB 53 Galenea 53 kallikrein 53 Preclinical studies suggest 53 stem cell biology 53 Velcura 53 Lupuzor 53 hereditary emphysema 53 Alfacell proprietary ribonuclease 53 NanoCrystal technology 53 metalloenzymes 53 histone deacetylase 53 small molecule activators 53 Oracea TM 53 MediVas 53 brain penetrant 53 vitro diagnostics 53 Memryte 53 THR beta agonist 53 Cyclosert TM 53 Anticalin 53 LHRH antagonists 53 vascular disrupting agent 53 Acologix 53 Selective Electrochemical Tumor Ablation 53 Cogane 53 XmAb ™ 53 genomic proteomic 53 herpes simplex viruses 53 IL-#/# 53 biodefence 53 SR Pharma 53 MAbs targeting 53 degenerative diseases 53 vitro assay 53 commercializing novel biotherapeutics 53 metabolite profiling 53 Cx# [002] 53 multiplex assay 53 immuno inflammatory 53 synthetic siRNA 53 Nasdaq MITI biopharmaceutical 53 IMiDs 53 Mirna Therapeutics 53 tyrosine kinase inhibitor 53 Mipomersen 53 imaging radiopharmaceuticals 53 biosimilar 53 bioimaging 53 GelSite R polymer 53 defensin mimetic antibiotic 53 Chemokine Therapeutics 53 proprietary transdermal 53 GPR# agonists 53 hypoxia activated prodrug 53 radiation sensitizer 53 Novasome R 53 VentiRx 53 HCV polymerase 53 ERYtech 53 chemotherapeutic drugs 53 Firazyr ® 53 DsiRNA molecules 53 enhance ApoA 53 molecular diagnostic assays 53 developing topically administered 53 Dalbavancin 53 Can Fite 53 lentiviral vector 53 immunotoxins 53 Jennerex 53 Eliezer Zomer Ph.D. 53 dasatinib Sprycel 53 Isogenica 53 Clofarabine 53 CYT# potent vascular disrupting 53 carbohydrate polymers 53 Icatibant 53 anticancer treatments 53 vinca alkaloid 53 plasma derived 53 orthobiologic 53 Anti Infectives 53 Nuon Therapeutics 53 Zolinza 53 CEQ# 52 ETBs 52 vaccine GRNVAC1 52 investigational monoclonal antibody 52 opioid antagonists 52 Carfilzomib 52 Kleanthis G. Xanthopoulos Ph.D. 52 A1PI 52 NeuroTrans TM 52 OGeS 52 membrane receptors 52 Anidulafungin 52 Nanobodies R 52 Xencor 52 ANAVEX 52 TTR amyloidosis 52 TransMolecular 52 immatics 52 Protein Therapeutics 52 ImmunoCellular Therapeutics 52 oral immunomodulatory 52 haemostasis 52 NDDS 52 mda 7 52 Aptamer 52 Virulizin 52 ribonucleotide reductase clinically validated 52 sd rxRNA 52 Smac mimetics 52 inflammatory bowel diseases 52 bispecific antibody 52 Micromet BiTE 52 receptor modulators 52 infectious diseases autoimmune diseases 52 Central Nervous System 52 MabThera rituximab 52 Pulmatrix 52 hemorrhagic fever viruses 52 siRNAs targeting 52 transfection reagent 52 CHDI 52 Chemetics R 52 Inflazyme 52 MP4 molecule 52 Dicerna 52 cannabinor 52 ZEVALIN ® 52 Pertuzumab 52 Viprovex TM 52 NP2 Enkephalin 52 protein misfolding 52 CDP# 52 ProLindac 52 Nasdaq ASTM 52 Nasdaq LXRX biopharmaceutical 52 gallium containing 52 vaccinology 52 polymer conjugate technology 52 neural stem cell 52 oral anticancer 52 acting muscarinic antagonist 52 metaglidasen 52 oral gallium 52 translational research 52 HTS assay 52 gene silencing 52 Mersana 52 immunomodulatory therapy 52 clinically differentiated 52 Locked Nucleic Acid 52 ZFP Therapeutic 52 TARIS 52 ActivX 52 siRNA conjugates 52 Callisto Pharmaceuticals Inc. 52 nanoparticle formulation 52 Synergy Pharmaceuticals 52 monoclonals 52 ProNAi 52 Milnacipran 52 RNA interference 52 hematologic malignancies 52 Nasdaq CYTR biopharmaceutical 52 molecular pathology 52 diarrhea predominant irritable 52 antisense oligonucleotide 52 CoMentis 52 Nanotope 52 Cancer Therapeutics 52 AQUA ® 52 AnaptysBio 52 Neogenix 52 PI3K inhibitor 52 Homspera ® 52 targeted immunotherapies 52 therapeutically relevant 52 pan HDAC inhibitor 52 tramiprosate 52 anti secretory 52 Ustekinumab 52 RayBiotech 52 nutraceuticals 52 immunodiagnostics 52 selective immunoproteasome inhibitor 52 Factor NGF 52 DermTech International 52 Affimed Therapeutics AG 52 oral ghrelin agonist 52 GGF2 52 neurotechnology 52 GCSF 52 Phase IIb clinical trials 52 molecular chaperone amplification 52 Elixir Pharmaceuticals 52 bafetinib 52 Nasdaq MBRX announced 52 Alnylam RNAi 52 biocatalysts